Clinical trial
Pilot Evaluation of CVT-E002 in Pediatric Upper Respiratory Tract Infection.
NCT00255307 · CV Technologies, Industry · Completed
Key facts
| NCT number | NCT00255307 |
|---|---|
| Title | Pilot Evaluation of CVT-E002 in Pediatric Upper Respiratory Tract Infection. |
| Official title | A Pilot Evaluation of Two Dosing Schedules of American Ginseng Extract in Pediatric Upper Respiratory Tract Infection. |
| Lead sponsor | CV Technologies, Industry |
| Collaborators | University of Alberta Capital Health, Canada |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Upper Respiratory Infection |
| Intervention type | Drug |
| Interventions | CVT-E002 ginseng extract |
| Enrollment | 75 |
| Start date | Nov 1, 2005 |
| Completion | Apr 1, 2006 |
| First posted | Nov 18, 2005 |
| Last update posted | Jun 18, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: